Progyny's Q3 2024 financials show minimal revenue growth, declining margins, and lower earnings per share. Read why I have sold my PGNY shares.

For the third quarter, CyberArk posted earnings per share of $0.94, significantly surpassing analyst expectations of $0.46 ...

Analysis of Nice vs Amazon Connect in the CCaaS market. Nice's strong fundamentals compete with Amazon's leverage of AWS ...

We recently published a list of 15 AI News That Broke The Internet This Week. In this article, we are going to take a look at ...

Discover how Amazon's AWS and retail sales are driving growth in Q3'24, fueled by demand for compute, AI services, and ...

The Trump-inspired stock market rally dried up further as investors heeded concerns about more hawkish monetary policy, ...

We recently compiled a list of the 15 AI Stocks That Are Dominating Headlines. In this article, we are going to take a look ...

Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...

There will be others, especially as its bottom line and free cash flow are impressive. The company's net income grew by 54.5% ...

Is the future of finance already written in the DNA of today's emerging technologies? Cathie Wood, CEO and CIO of Ark Invest, ...

While Amazon thrives at being the "everything store" that prioritizes selling mass-market goods with fast and free delivery, ...

Chipmaker and software specialist Broadcom continues to generate robust growth, fueling the next generation of artificial ...